Filgotinib in Long-Term Extension Study of Adults With Ulcerative Colitis
Clinical trial NCT02914535 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT02914535
- Sponsor
- Alfasigma S.p.A.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2017-02-23
- Primary completion
- 2026-09-01
- Enrollment
- 1173
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.